AMCPX
Price
$41.33
Change
-$0.11 (-0.27%)
Updated
May 9 closing price
Net Assets
84.6B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

AMCPX vs RGAHX

Header iconAMCPX vs RGAHX Comparison
Open Charts AMCPX vs RGAHXBanner chart's image
American Funds AMCAP A
Price$41.33
Change-$0.11 (-0.27%)
VolumeN/A
Net Assets84.6B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
AMCPX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMCPX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCPX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. AMCPX (84.6B). RGAHX pays higher dividends than AMCPX: RGAHX (0.54) vs AMCPX (0.38). AMCPX was incepted earlier than RGAHX: AMCPX (58 years) vs RGAHX (9 years). AMCPX (0.67) is less costly to investors than RGAHX (0.44). AMCPX is a more actively managed with annual turnover of: 27.00 vs. RGAHX (25.00). AMCPX (250) and RGAHX (250) have matching initial minimum investment requirements. RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. AMCPX (-0.11). RGAHX return over 5 years is better than : 44.87 vs. AMCPX (30.58).
AMCPXRGAHXAMCPX / RGAHX
Total Expense Ratio0.670.44152%
Annual Report Gross Expense Ratio0.670.44152%
Fund Existence58 years9 years-
Gain YTD-3.254-2.478131%
Front Load6%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets84.6B285B30%
Annual Yield % from dividends0.380.5469%
Returns for 1 year-0.113.25-3%
Returns for 3 years25.5533.4076%
Returns for 5 years30.5844.8768%
Returns for 10 years42.75N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics